The aggressive nature of TSCC may result from at least two opposing forces: a) increased T regs and decreased CD8+ T cells, leading to decreased immune surveillance, and b) increased exposure to IL-22, which may provide a proliferative stimulus and accelerate tumor growth. The gene discussed is IL22; the disease is neoplasm.